These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16856918)

  • 41. 'Rainy day' stem cell storage for adult patients with acute myeloid leukaemia in first complete remission.
    Marks DI
    Intern Med J; 2008 Aug; 38(8):680-1; author reply 681. PubMed ID: 18808569
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of acute leukemia with allogeneic stem cell transplantation].
    Seiwerth RS; Mrsić M; Nemet D; Bogdanić V; Mikulić M; Sertić D; Grković L; Cecuk E; Bojanić I; Batinić D; Labar B
    Acta Med Croatica; 2009 Jun; 63(3):205-8. PubMed ID: 19827346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterogeneous loss of the Y chromosome in leukocyte lineages of donor origin after stem cell transplantation.
    Buño I; Kwon M; Balsalobre P; Serrano D; Carrión R; Gómez-Pineda A; Díez-Martín JL
    Bone Marrow Transplant; 2006 Sep; 38(6):463-5. PubMed ID: 16892070
    [No Abstract]   [Full Text] [Related]  

  • 44. Tuberculoma of the brain: a series of 16 cases treated with anti-tuberculosis drugs.
    Idris MN; Sokrab TE; Arbab MA; Ahmed AE; El Rasoul H; Ali S; Elzubair MA; Mirgani SM
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):91-5. PubMed ID: 17217136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach.
    Lodewyck T; Cornelissen JJ
    Blood Rev; 2008 Nov; 22(6):293-302. PubMed ID: 18455284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolated testicular and bone relapse in children with acute myeloblastic leukemia and chronic graft versus host disease after allogeneic BMT.
    Yildirim I; Uçkan D; Cetin M; Tuncer M; Tezcan I
    Turk J Pediatr; 2007; 49(2):206-9. PubMed ID: 17907524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Intracranial tuberculoma].
    Nakamura H; Ibayashi S; Fujishima M; Saku Y
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):180-3. PubMed ID: 10201170
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cord blood transplantation after successful treatment of brain abscess caused by Bacillus cereus in a patient with acute myeloid leukemia].
    Kuwabara H; Kawano T; Tanaka M; Kobayashi S; Okabe G; Maruta A; Nagao T; Ishigatsubo Y; Mori H
    Rinsho Ketsueki; 2006 Nov; 47(11):1463-8. PubMed ID: 17176890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tuberculoma of Eloquent Brain.
    Karthigeyan M; Salunke P; Siroliya A
    Am J Trop Med Hyg; 2021 May; 105(1):4-5. PubMed ID: 33970890
    [No Abstract]   [Full Text] [Related]  

  • 50. The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease.
    Kim SY; Lee DG; Kim MS; Kim HJ; Lee S; Min CK
    Am J Hematol; 2008 Oct; 83(10):784-8. PubMed ID: 18661492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.
    Aversa F
    Bone Marrow Transplant; 2008 Mar; 41(5):473-81. PubMed ID: 18176612
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytogenetically normal acute myeloid leukemia.
    Narimatsu H
    N Engl J Med; 2008 Aug; 359(6):652; author reply 652-3. PubMed ID: 18697248
    [No Abstract]   [Full Text] [Related]  

  • 54. Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia.
    Nakaseko C; Sakaida E; Ohwada C; Ozawa S; Takeuchi M; Shimizu N; Cho R; Yokota A; Saito Y; Nishimura M
    Ann Hematol; 2007 Jan; 86(1):67-9. PubMed ID: 17021838
    [No Abstract]   [Full Text] [Related]  

  • 55. Successful interim therapy with imatinib prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute myeloid leukemia.
    Cho BS; Kim HJ; Lee S; Eom KS; Min WS; Lee JW; Kim CC
    Eur J Haematol; 2007 Aug; 79(2):170-3. PubMed ID: 17608710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fatal hemorrhagic intracranial TB in a renal transplant recipient despite INH prophylaxis.
    Abutaleb N; Obaideen A; Hamza A; Zakaria M; Afifi H; Fallata S; Younis S; Adem M
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):594-8. PubMed ID: 17951949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia.
    Bitan M; Or R; Shapira MY; Resnick IB; Gesundheit B; Ackerstein A; Samuel S; Elad S; Slavin S
    Bone Marrow Transplant; 2008 Jan; 41(1):69-78. PubMed ID: 17994125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Choi Y; Min WS; Kim TG; Cho BS; Kim SY; Eom KS; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim CC
    Transplantation; 2007 Nov; 84(9):1082-91. PubMed ID: 17998861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.
    Maurillo L; Buccisano F; Del Principe MI; Del Poeta G; Spagnoli A; Panetta P; Ammatuna E; Neri B; Ottaviani L; Sarlo C; Venditti D; Quaresima M; Cerretti R; Rizzo M; de Fabritiis P; Lo Coco F; Arcese W; Amadori S; Venditti A
    J Clin Oncol; 2008 Oct; 26(30):4944-51. PubMed ID: 18606980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.